The use of metformin for women with PCOS undergoing IVF treatment

Human Reproduction

Volumn 21, Issue 6, 2006, Pages 1416-1425

  Tang, Thomas ^a   Glanville, Julie ^a   Orsi, Nic ^a   Barth, Julian H ^a   Balen, Adam H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

IVF; Metformin; OHSS; Polycystic ovary syndrome; Pregnancy

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; METFORMIN; NAFARELIN ACETATE; PLACEBO; PROGESTERONE; RECOMBINANT FOLLITROPIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG DOSE REGIMEN; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SHORT COURSE THERAPY; TREATMENT OUTCOME;

EID: 33745670469     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del025     Document Type: Article

References (81)

1. Abbott DH, Dumesic DA and Franks S (2002) Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174 (1),1-5.
2. Abbott DH, Barnett DK, Bruns CM and Dumesic DA (2005) Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11 (4),357-374.
3. Adams J, Franks S, Polson DW, Mason HD and Jacobs HS (1985) Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 2,1375-1379.
4. Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, Tan SL, Campbell S and Jacobs HS (1998) Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 13 (3),651-655.
5. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Conway G and Jacobs H (1999) Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 71 (2),287-293.
6. Agrawal R, Jacobs H, Payne N and Conway G (2002) Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78 (6),1170-1171.
7. Andreani CL, Pierro E, Lanzone A, Lazzarin N, Capitanio G, Giannini P and Mancuso S (1994) Effect of gonadotropins, insulin and IGF I on granulosa luteal cells from polycystic ovaries. Mol Cell Endocrinol 106 (1-2),91-97.
8. Attia GR, Rainey WE and Carr BR (2001) Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 76 (3),517-524.
9. Balen AH and Michelmore K (2002) What is polycystic ovary syndrome? Are national views important? Hum Reprod 17,2219-2227.
10. Balen AH, Tan SL, MacDougall J and Jacobs HS (1993) Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 8 (6),959-964.
11. Balen AH, Braat DD, West C, Patel A and Jacobs HS (1994) Cumulative conception and live birth rates after the treatment of anovulatory infertility: Safety and efficacy of ovulation induction in 200 patients. Hum Reprod 9 (8),1563-1570.
12. Buyalos RP and Lee CT (1996) Polycystic ovary syndrome: Pathophysiology and outcome with in vitro fertilization. Fertil Steril 65 (1),1-10.
13. Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D and Barth JH (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: Validation of a method for routine clinical practice. Clin Chem 51 (8),1472-1479 [Epub 16 June 2005].
14. Check JH, Nazari A and Dietterich C (1995) Comparison of androgen levels in conception vs. non-conception cycles following controlled ovarian stimulation using the luteal phase gonadotropin-releasing hormone agonist protocol. Gynecol Endocrinol 9 (3),209-214.
15. Cheung AP, Pride SM, Yuen BH and Sy L (2002) In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome. Hum Reprod 17 (10),2540-2547.
16. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X and Norman R (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10,2705-2712.
17. Clark AM, Thornley Tomlinson L, Galletley C and Norman R (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13,1502-1505.
18. Costello M and Eden J (2003) A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 79,1-13.
19. Dale PO, Tanbo T and Abyholm T (1991) In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod 6 (2),238-241.
20. Dale PO, Tanbo T, Haug E and Abyholm T (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod 13 (3),567-570.
21. De Leo V, la Marca A, Ditto A, Morgante G and Cianci A (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome [see comment]. Fertil Steril 72 (2),282-285.
22. Delvigne A, Dubois M, Battheu B, Bassil S, Meuleman C, De Sutter P, Rodesch C, Janssens P, Remacle P and Gordts S (1993) The ovarian hyperstimulation syndrome in in-vitro fertilization: A Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum Reprod 8 (9),1361-1366.
23. Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E and Mashiach S (1990) The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: A comparison of results with those of patients with tubal infertility. Hum Reprod 5 (7),816-818.
24. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (6),774-800.
25. Engmann L, Maconochie N, Sladkevicius P, Bekir J and Campbell S, Tan SL (1999) The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 14 (1),167-171.
26. Fanchin R, de Ziegler D, Taieb J, Olivennes F, Castracane VD and Frydman R (2000) Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation. Fertil Steril 73 (2),275-279.
27. Fedorcsak P, Storeng R, Dale PO, Tanbo T and Abyholm T (2000) Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 79 (1),43-48.
28. Fedorcsak P, Dale PO, Storeng R, Tanbo T and Abyholm T (2001) The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 16 (6),1086-1091.
29. Fedorcsak P, Dale PO, Storeng R, Abyholm T and Tanbo T (2003) The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: An open-label randomized cross-over trial. Gynecol Endocrinol 17 (3),207-214.
30. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18 (1),4-25.
31. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Ferlini F, Perri T and Parmegiani L (2003) Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 80 (2),390-397.
32. Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J, Sattar N and Seifer DB (2005) Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 83 (1),130-136.
33. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, and Caspi E (1989) Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Surv 44 (6),430-440.
34. Gougeon A (1996) Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocr Rev 17 (2),121-155.
35. Haas DA, Carr BR and Attia GR (2003) Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 79 (3),469-481.
36. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS and Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12(1), 13-21.
37. Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J and Ben-Rafael Z (1993) In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 60 (5),858-863.
38. Jacobs HS and Agrawal R (1998) Complications of ovarian stimulation. Baillieres Clin Obstet Gynaecol 12 (4),565-579.
39. Katz A, Nambi S, Mather K, Baron AD, Follmann DA and Sullivan G (2000) Quantitative insulin sensitivity check index: A simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85,2402-2410.
40. Kjotrod SB, von During V and Carlsen SM (2004) Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 19 (6),1315-1322.
41. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y and Tanaka T (1995) High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 10 (8),1962-1967.
42. Kodaman PH and Taylor HS (2004) Hormonal regulation of implantation. Obstet Gynecol Clin North Am 31 (4),745-766, ix.
43. Lee A, Christenson LK, Stouffer RL, Burry KA and Patton PE (1997) Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 68 (2),305-311.
44. Lord JM, Flight IH and Norman RJ (2003) Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD003053. DOI: 10.1002/ 14651858.CD003053.
45. Ludwig M, Finas DF, al-Hasani S, Diedrich K and Ortmann O (1999) Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14 (2),354-358.
46. MacDougall MJ, Tan SL, Balen A and Jacobs HS (1993) A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 8 (2),233-237.
47. Machin D and Campbell M (1987) Statistical Tables for the Design of Clinical Trials. Blackwell, Oxford.
48. Mansfield R, Galea R, Brincat M, Hole D and Mason H (2003) Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril 79 (4),956-962.
49. la Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F and De Leo V (2002) Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril 78 (6),1234-1239.
50. Mason HD, Margara R, Winston RM, Seppala M, Koistinen R and Franks S (1993) Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J Clin Endocrinol Metab 76 (5),1275-1279.
51. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S and Van Obberghen E (2000) Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275 (28),21695-21702.
52. Munster K and Schmidt Lone Helm P (1993) Length and variation in the menstrual cycle - a cross-sectional study from a Danish county. BJOG 99,422-429.
53. National Institute for Clinical Excellence on Fertility: Assessment and Treatment for People with Fertility Problems (2004) Royal College of Obstetricians and Gynaecologists Press.
54. Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338 (26),1876-1880.
55. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marme D and Breckwoldt M (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80 (6),1967-1971.
56. Okon MA, Laird SM, Tuckerman EM and Li TC (1998) Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 69 (4),682-690.
57. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J and Simon C (1999) The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 71 (3),482-489.
58. Poikkeus P, Hiilesmaa V and Tiitinen A (2002) Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod 17 (7),1901-1905.
59. Powell C, Orsi N, Simpson N and Levene M (2004) Characterisation of the cytokine inflammatory response in LPS stimulated full-term cord blood. J Perinat Med 32 (5),440-445.
60. Rose GL, Dowsett M, Mudge JE, White JO and Jeffcoate SL (1988) The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 49 (2),224-228.
61. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19,41-47 [Fertil Steril 81,19-25].
62. Stadtmauer LA, Toma SK, Riehl RM and Talbert LM (2001) Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 75 (3),505-509.
63. Steer CV, Mills CL, Tan SL, Campbell S and Edwards RG (1992) The cumulative embryo score: A predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 7 (1),117-119.
64. Sunder S and Lepton EA (2000) Endocrinology of the peri-implantation period. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (5),789-800.
65. Suzuki Y, Sugiyama R, Fukumine N, Usuda S, Itoh H, Isaka K, Takayama M and Teisner B (2000) Clinical applications of serum placental protein 14 (PP14) measurement in the IVF-ET cycle. J Obstet Gynaecol Res 26 (4),295-302.
66. Takeuchi T, Nishii O, Okamura T, Yaginuma T and Kawana T (1993) Free testosterone and abortion in early pregnancy. Int J Gynaecol Obstet 43 (2),151-156.
67. Tang T, Glanville J, Hayden CJ, White D, Barth JH and Balen AH (2006) Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21 (1),80-89.
68. Tasdemir S, Ficicioglu C, Yalti S, Gurbuz B, Basaran T and Yildirim G (2004) The effect of metformin treatment to ovarian response in cases with PCOS. Arch Gynecol Obstet 269 (2),121-124.
69. Teissier MP, Chable H, Paulhac S and Aubard Y (1999) Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: Effects in mature follicle endocrinology. Hum Reprod 14 (9),2236-2241.
70. Teissier MP, Chable H, Paulhac S and Aubard Y (2000) Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: Relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod 15 (12),2471-2477.
71. Tsilchorozidou T, Overton C and Conway GS (2004) The pathophysiology of polycystic ovary syndrome. Clin Endocrinol 60 (1),1-17.
72. Urman B, Fluker MR, Yuen BH, Fleige-Zahradka BG, Zouves CG and Moon YS (1992) The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril 57 (6),1269-1273.
73. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW and Nestler JE (2001) Metformin increases the ovulatary rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75 (2),310-315.
74. Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS and Soong YK (2002) Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87 (7),3300-3308.
75. Wass P, Waldenstrom U, Rossner S and Hellberg D (1997) An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod 12 (9),2057-2060.
76. Westergaard LG, Wiberg N, Andersen CY, Laursen SB, Kliem A, Westergaard JG and Teisner B (1998) Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. Hum Reprod 13 (9),2612-2619.
77. Westergaard LG, Yding Andersen C, Erb K, Laursen SB, Rasmussen PE, Rex S and Teisner B (2004) Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI. Reprod Biomed Online 8 (1),91-98.
78. Whelan JG III and Vlahos NF (2000) The ovarian hyperstimulation syndrome. Fertil Steril 74 (5),1059-1060.
79. Wijeyaratne CN, Balen AH, Barth JH and Belchetz PE (2002) Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among south Asians and Caucasians: Is there a difference? Clin Endocrinol 57,343-350.
80. Wu XK, Zhou SY, Liu JX, Pollanen P, Sallinen K, Makinen M and Erkkola R (2003) Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 80 (4),954-965.
81. Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O and Koray Z (2002) Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod 17 (2),289-294.